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Culture remains the ‘gold standard’ for diagnosis of Streptococcus pneumoniae 
bacteraemia. Time to definitive identification using culture is 24–48 hours, and prior 
antibiotic therapy, the ability of S. pneumoniae to self-autolyse and its fastidious nature 
can yield no growth on culture. Novel detection methods for invasive pneumococcal 
disease include PCR and antigen tests. We evaluated using a urine antigen test 
directly on selected blood cultures with appropriate Gram stain results, immediately 
after signalling positive for the rapid identification of S. pneumoniae bacteraemia. 
 
Method: 
We collected 212 blood cultures that had signalled positive with an automated blood 
culture system, and then yielded gram-positive cocci in pairs/chains or cocci with 
uncertain morphological arrangement. The BinaxNOW Streptococcus pneumoniae 
urinary antigen test, routine culture with optochin and real time lytA PCR was 
performed on all samples. Diagnostic accuracy analysis (sensitivity and specificity) of 
the antigen test and Gram stain with gram-positive cocci in pairs was each compared 
to culture positivity for S. pneumoniae, PCR positivity and the composite of culture or 
PCR positivity for S. pneumoniae as the reference standards.   
 
Results: 
S. pneumoniae (Spn) was cultured in 55 samples, gram-positive organisms other than 
S. pneumoniae (NSpn) in 140 samples and 17 samples had no growth (NG). Gram-
positive cocci in pairs was predominant on Gram stain in the Spn/NG groups whilst 
the minority in the NSpn group. 
In the Spn group, all except 1 sample which was antigen positive but PCR negative, 
were antigen and PCR positive. In the NSpn group, antigen and PCR was negative in 
123 samples, antigen and PCR positive in 1 sample and antigen positive but PCR 
negative in the remaining 16 samples. In the NG group, antigen and PCR were positive 
in 16 samples and antigen positive but PCR negative in 1 sample.  
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Sensitivity of the antigen test compared to culture, PCR or the composite of culture or 
PCR was 100%. Specificity was 87-88% but increased to 93-96% when used in 
subsets with gram-positive cocci in pairs or clinical history compatible with respiratory 
illness or meningitis. Sensitivity and specificity of the antigen test when compared to 
Gram stain using gram-positive cocci in pairs (69%-75% and 81% respectively) were 
both higher. 
 
Discussion and Conclusion:   
Accurate and rapid diagnosis of S. pneumoniae bacteraemia is challenging with 
current diagnostic tools. Specificity of the antigen test is mostly limited by cross-
reactivity with viridans streptococci, coagulase negative staphylococci and 
enterococcus species, but this can be overcome if Gram stain morphology and clinical 
history is available. Sensitivity and specificity of Gram stain alone in predicting S. 
pneumoniae bacteraemia is poor and is increased with use of the antigen test. 
The antigen test is a useful adjunctive tool improving diagnosis and turnaround time 
of S. pneumoniae bacteraemia. In settings like ours, where high-level resistance, 
defined as minimum inhibitory concentration ≥2μg/mL to penicillin is still relatively low 
(~7%), rapid de-escalation to penicillin in the appropriate clinical setting would be 
possible with the introduction of such test and could also potentially be a suitable 
alternative to molecular testing for S. pneumoniae identification in samples with no 
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Chapter 1: Introduction and Literature review 
S. pneumoniae can cause serious invasive disease resulting in meningitis, 
bacteraemia or infection of other normally sterile sites(1, 2). The World Health 
Organisation (WHO), in 2005, estimated that 1.6 million people die from invasive 
pneumococcal disease (IPD) annually and that children under the age of 5 and those 
from developing countries are most affected(3). Non-invasive manifestations are more 
common, less severe and include pneumonia without bacteraemia, otitis media, 
sinusitis and bronchitis(3).  
National surveillance is central in evaluating IPD burden in countries like South Africa 
where multiple preventative strategies such as the introduction of pneumococcal 
conjugate vaccines for children and high-risk individuals, and improved access to HIV 
care are occurring. Accurate diagnosis of IPD is fundamental in determining true 
disease burden, accurate antimicrobial resistance profiles (falsely identifying other 
streptococcal species as S. pneumoniae incorrectly drives up the rates of resistance, 
as many of these organisms tend to be penicillin and multidrug resistant) and the 
efficacy of interventions to prevent IPD(2, 4).  
South Africa has an active laboratory-based surveillance program for pathogens of 
public health importance and includes an extensive database on S. pneumoniae 
IPD(5). Isolates from microbiology laboratories nationally, in both the public and 
private sector, are sent to GERMS-SA, a group under the Division of Public Health, 
Surveillance and Response in the National Institute for Communicable Diseases 
(NICD), South Africa, for serotyping and characterisation(5). Most isolates are 
recovered from public sector laboratories that service over 80% of the country’s 
population(6). In 2009, a 7-valent pneumococcal conjugate vaccine (PCV) was 
introduced into the routine infant immunization program in South Africa and was 
replaced with the 13- valent pneumococcal conjugate vaccine in 2011(7).  
Surveillance data from GERMS-SA between 2005 and 2012 showed that overall IPD 
incidence rates decreased from 9.4 to 5.7 cases per 100 000 person years, with an 
even more substantial decrease in children less than 2 years of age where cases 
decreased from 54.8 to 17.0 cases per 100 000 person years (7). However, in HIV 
uninfected children the incidence of nonvaccine serotype IPD increased by 33%(7). 
Current GERMS-SA surveillance data from 2017, report that the IPD incidence 
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nationally was 4.32 per 100 000 person years but rates varied by province, ranging 
from 1.28 per 100 000 person years in Limpopo to 10.37 per 100 000 person years in 
the Western Cape(8). The above is consistent with data from other countries 
demonstrating a reduction in the number of cases and deaths with the introduction of 
PCV, however despite this reduction, IPD is still a cause of significant morbidity and 
mortality(9). In South Africa, the majority of IPD episodes in 2017 were from blood 
cultures (61%) and cerebrospinal fluid (32%). Samples from other sterile sites 
accounted for the remaining 7%(8). 
For decades, diagnosis of IPD has relied on culture and this has been the reference 
method in routine diagnostic laboratories. Culture is limited by many factors including 
prior antibiotic administration to sample collection, autolysin production by the 
organism which causes the organism to self-autolyse and die and the fastidious nature 
of S. pneumoniae imposing requirements for enriched media and specialised 
incubation conditions(10-13). Additional factors not specific to S. pneumoniae like low 
levels of the organism in the sample, delays in transporting specimens to the 
laboratory, delays in sub-culturing specimens onto appropriate media and delays in 
incubation of media in the appropriate culture environment also affect growth and limit 
the utility of culture. Upon growth of the organism, S. pneumoniae is differentiated from 
other streptococci based on colony morphology, alpha haemolysis on blood agar and 
susceptibility to optochin (ethylhydrocupreine) which can also be problematic(10, 14, 
15).  One study reported that approximately 10% of their S. pneumoniae isolates were 
resistant to optochin(14). In such cases, identification was usually confirmed by 
performing the bile solubility test, which is based on autolysis of the organism in the 
presence of sodium deoxycholate (10, 14, 15). Isolates of S. pneumoniae that are bile 
insoluble have also been described but the prevalence is low (~1%)(14). Despite the 
numerous complexities around culture, it persists as the method of choice as no 
perfect alternative for diagnoses of IPD has yet been described.  
Newer laboratory detection methods for S. pneumoniae infection include molecular 
methods (such as PCR) and immunochromatographic antigen detection tests 
(ICT)(10). PCR techniques are usually highly sensitive because they are able to detect 
small amounts of target nucleic acid in clinical specimens and are also able to detect 
non-viable organisms (10, 16, 17). PCR is also less influenced by prior antimicrobial 
therapy and results can be provided within a short time frame if PCR is easily 
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accessible(10, 13). Conversely, molecular techniques are limited by cost, availability 
in routine clinical laboratories and a delay in obtaining the results when the test is not 
easily available(10, 13, 18). Multiple gene targets (ply, lytA, psaA, sodA, and pbp) for 
the identification of S. pneumoniae have been assessed with variable diagnostic 
accuracy parameters being reported(17). Two commonly used targets are the ply and 
lytA gene(10). The WHO recommends that the lytA PCR, developed by the Centre for 
Disease Control and Prevention (CDC) in Atlanta, be used as a non-culture-based 
method to identify S. pneumoniae(16, 17). Most of these pneumococcal gene targets 
used for PCR thus far demonstrate compromised specificity due to cross-reactivity 
with other closely related streptococcal species such as S. mitis and S. oralis(17) . A 
study looking at relatedness between S. pneumoniae and other streptococcal species 
by analysing the whole genome sequences of the strains tested, found that ~48% of 
the pneumococcal genome (998 057 base pairs) could be aligned against other 
streptococcal  species (19). Given the genetic relatedness between S. pneumoniae 
and other members of the streptococcus mitis group, as well as its ability to acquire 
genetic material from other streptococcal species in its environment through 
transformation and recombination, it has been difficult to use a single gene in isolation 
to accurately discriminate S. pneumoniae from other streptococcal species (19, 20). 
Recently, the novel “Xisco” gene has been identified as a potential gene target that 
has demonstrated improved sensitivity and specificity for the identification of S. 
pneumoniae in silico and in vitro (100%) and may in the future supercede culture and 
lytA PCR as the recommended diagnostic tool for IPD (21). But for now, the overall 
poor specificity of PCR has led researchers to look at other molecular methods such 
as 16s RNA analyses, PCR followed by restriction fragment length polymorphism 
analysis of the lytA gene, multilocus sequence typing analysis and whole genome 
sequencing for accurate identification (17). Whilst these tests may be highly 
discriminatory, their place in routine diagnostic laboratories especially in the 
developing world will not be feasible due to the complexity of testing, interpretation of 
results and the associated cost.   
ICT is being used more commonly as a complementary test to diagnose S. 
pneumoniae infection. Advantages of ICT include being easy and rapid to perform with 
a short turnaround time to providing a result (~15 minutes), being culture independent, 
being unaffected by prior antibiotic therapy and being cheaper than molecular 
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methods(10, 13). The BinaxNOW Streptococcus pneumoniae Antigen Card test is an 
ICT test based on the detection of the C-polysaccharide cell wall protein which is 
common to all S. pneumoniae serotypes, by using a sandwich assay on a 
nitrocellulose strip(12, 18, 22, 23). It has been validated for use on urine samples to 
assist in the diagnosis of community-acquired pneumonia (CAP), and for use on 
cerebrospinal fluid (CSF) to assist in the diagnosis of pneumococcal meningitis(11, 
12, 24). A systematic review and meta-analysis concluded that the pooled sensitivity 
and specificity of the test when used on urine for the diagnosis of community-acquired 
pneumonia in adult hospitalized patients is 74% and 97% respectively(22). It’s use in 
children for diagnosis of CAP is limited because of higher levels of S. pneumoniae 
colonisation in the nasopharynx yielding false positive results in healthy carriers (18, 
25, 26). With regards to CSF, the sensitivity and specificity is higher in patients who 
presented with symptoms of meningitis. A 2001 study reported a sensitivity and 
specificity of 100%, but was limited by  the small sample size and the exclusion of 
children.(23). A study in 2002 with a much larger sample size and including both 
children and adults, reported a sensitivity of 95% and a specificity of 100%(18). 
Although not validated for use on other samples, the BinaxNOW Streptococcus 
pneumoniae Antigen Card test has aided in the diagnosis of IPD in other sterile sites 
such as pleural and pericardial fluid infection(13, 27).  
This led to the consideration of the BinaxNOW Streptococcus pneumoniae Antigen 
Card test as an alternative for the diagnosis of S. pneumoniae bacteraemia, 
particularly in culture-negative specimens. Petti and colleagues tested broth from 
blood culture bottles that had cultured S. pneumoniae and showed that ICT remained 
positive after isolates became non-viable on culture by testing blood culture broth on 
day 2 and day 30 after signalling positive(12). Baggett and colleagues, tested 182 
blood culture negative specimens that had signalled positive and reported that the 
antigen test was positive in 43 (24%) specimens, potentially increasing the yield of S. 
pneumoniae diagnosis(11). However, no confirmatory tests were performed, and false 
positives results could not be excluded(11). In the study by Saha and colleagues, 10 
culture-negative specimens that were brown or ‘chocolate’ coloured in appearance 
were tested using ICT and confirmatory ply PCR. S. pneumoniae was detected in eight 
of these samples with a positive ICT and positive PCR result. The remaining 2 samples 
were both negative on ICT and PCR(28). A further study compared the BinaxNOW 
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Streptococcus pneumoniae Antigen Card test with three different latex agglutination 
kits(29). All four tests were performed directly on blood culture broth that had flagged 
positive with gram-positive cocci in pairs or chains on microscopy(29) . Compared to 
the other kits, the BinaxNOW Streptococcus pneumoniae Antigen Card test had the 
best sensitivity (100% vs 99.6% in each of the other methods) but the worst specificity 
(64% vs 82 – 89%) as it cross reacted with other streptococcal species, mostly S. mitis 
and S. oralis, and enterococcal species(29). Most recently Moisi and colleagues 
compared the BinaxNOW Streptococcus pneumoniae antigen test and lytA PCR 
directly on signal positive blood cultures in Mali and Thailand(30). Compared to routine 
culture both ICT and lytA PCR had limited sensitivity (ICT 87-100% and lytA PCR 90-
100%) and specificity (ICT 96-100% and lytA PCR 98-100%) with lytA PCR 
outperforming ICT (30).  
It is clear that there is no perfect test for the laboratory detection of S. pneumoniae 
despite numerous variations of multiple test methods becoming available. The 
BinaxNOW Streptococcus pneumoniae Antigen Card test and lytA PCR have been 
used to diagnose S. pneumoniae bacteraemia directly on blood culture broth(11, 12, 
28, 30). The sensitivity of both methods has been good but limitations in specificity 
have been described for both and has been attributed to relatedness and horizontal 
gene transfer between streptococcal species(19). These features are unlikely to 
change in the organism itself and currently it would appear, given the test methods 
available to the routine diagnostic laboratory, that accurate diagnosis of S. 
pneumoniae infection may sometimes be complicated and more advanced molecular 
tools, like whole genome sequencing, may be necessary to differentiate between S. 
pneumoniae and its closely related relatives. Despite the unavailability of the perfect 
test, the reality is that practical strategies are required for rapid and accurate 
identification of S. pneumoniae from clinical specimens especially in developing 
countries where the burden of disease is highest, and resources limited. 
The focus of this study will be to determine the suitability of the BinaxNOW 
Streptococcus pneumoniae Antigen Card test for the identification of S. pneumoniae 
from blood culture samples immediately when Gram stain is suggestive of 
pneumococcus as being the causative organism of infection. In our setting, if the test 
is found to be accurate, this would prevent the typical time delay (between 24 – 48 
hours) for identification by phenotypic methods (colony morphology, alpha haemolysis 
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on blood agar and susceptibility to optochin). If the organism is not viable a further 
delay would occur as molecular testing is not available on site and the sample would 
be sent to a reference laboratory, where tests are done in batches and results are not 
available in real time, having no impact on clinical management. We hypothesis that 
in these culture-negative cases, ICT testing will be a suitable alternative to molecular 
testing for the identification of S. pneumoniae bacteraemia. If true, this will be 
beneficial to other laboratories where access to molecular diagnostic tools is 
challenging. We hope to show that despite its reported limitations with specificity, a 
positive ICT result from blood culture with a suggestive Gram stain, in combination 
with a common compatible clinical manifestation of S. pneumoniae IPD, aids in the 
rapid identification of the organism with the potential to have an impact on patient care  
and antibiotic stewardship in settings like ours, where high level penicillin resistance, 
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Chapter 2: Methods 
A prospective study was carried out at the National Health Laboratory Service, Groote 
Schuur Microbiology Laboratory, Cape Town, South Africa, between June 2017 and 
March 2018. The laboratory provides diagnostic microbiology services to seven 
hospitals, as well as to surrounding clinics, that drain an approximate population of 
1.85 million people from predominantly low socio-economic backgrounds. The 
laboratory receives approximately 40 000 blood cultures annually and uses the 
BacT/ALERT automated blood culture system for bacterial culture and enrichment 
(bioMererieux Inc., Durham, NC, USA). These systems signal positive after detecting 
a change in signal fluorescence in the blood culture bottles, indicating possible growth 
of an organism. Aliquots from blood culture bottles which signal positive within 5 days 
(120 hours) of incubation are Gram stained by laboratory staff and examined with light 
microscopy to detect organisms present. Aliquots of blood culture broth are inoculated 
onto routine culture media and incubated overnight. Clinically significant blood culture 
Gram stain results are relayed telephonically to clinicians as soon as possible and 
clinical details including clinical presentation, admitting hospital and antibiotic 
administration are collected by microbiology pathologists-in-training as part of the 
routine service provided. 
For this study, aliquots of blood culture broth were collected by the investigator from 
samples where the Gram stain morphology was suggestive of S. pneumoniae, i.e. 
gram-positive cocci in pairs or chains, as well as gram-positive cocci where it was 
difficult to determine whether the cocci were forming clusters, pairs or chains. 
BinaxNOW Streptococcus pneumoniae Antigen Card Test (Alere) (ICT) and PCR were 
performed on the aliquots as described below. Clinical information collected by 
microbiology pathologists-in-training was collated.  Dates and times of incubation in 
the automated blood culture system, signal detection by the automated blood culture 
system and authorisation of final sample reports were collected from the BacT/ALERT 
automated blood culture instrument and the NHLS-LABTRAK laboratory information 
system respectively. Time interval from incubation to signalling positive was 
determined to see if there was any difference in growth patterns between samples 
after grouping by culture results. Time interval from incubation to authorisation was 
calculated and used as a proxy to determine if there were any differences in 
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turnaround time for identification between samples after grouping by culture results. 
The presence of autolysis was determined based on the colour of the blood culture 
broth. All samples that had an obviously chocolate or brown colour appearance were 
classified as having undergone autolysis and this was determined by the investigator 
prior to performing ICT.    
Culture: 
Blood culture broth was processed using the laboratory standard operating procedure 
(SOP), by inoculating broth onto 2% horse blood agar and 5% sheep blood agar. The 
sheep blood agar had a 5μg optochin disc placed on the inoculum. Both plates were 
incubated in 5% CO2 and checked at 24 and 48 hrs for growth of alpha haemolytic 
streptococci and the presence of a zone of inhibition around the optochin disk. If the 
zone of inhibition was ≥ 14 mm around the optochin disk, the organism was identified 
as S. pneumoniae(31). If the zone of inhibition was < 14 mm, the isolate was further 
identified using the Vitek 2 GP-ID card according to the manufacturer’s instructions. 
BinaxNOW Streptococcus pneumoniae Antigen Card Test (ICT): 
Aliquots of blood culture broth were tested by the investigator. Samples were selected 
based on Gram stain result after microscopy was performed independently by 
laboratory staff. The investigator was blinded to the clinical details obtained and 
performed the antigen test on the day the blood culture flagged positive. Briefly, the 
test is a lateral flow assay that has an internal control indicator line and an antigen 
detection indicator line. The antigen test detects the C-polysaccharide cell wall protein 
antigen which is common to S. pneumoniae serotypes(12, 18, 22, 23). Swabs provided 
by the manufacturer were submerged into a 1ml aliquot of blood culture broth and 
inserted into the test card. Reagent provided by the manufacturer was added and the 
test card securely sealed. Results were read 15 minutes after sealing the test card 
(looking for visualisation of the control and antigen indicator lines) and interpreted 
according to the package insert(24). The manufacturer considers any visible line, 
including faint lines, to be reactive. Faint reactive lines were recorded, since reports of 
cross reactivity of the test with other streptococcal species has previously been 





DNA extraction:  
DNA extraction of blood culture broth was performed using the QIAsymphony SP 
automated extraction instrument with the QIAsymphony Virus/Bacteria mini kit, 
according to the manufacturer’s instructions (Qiagen, Hilden, Germany). DNA 
extracted from 200 μl of blood culture broth was eluted into 60 μl of elution buffer and 
stored at -70° C. 
Real time lytA PCR:  
PCR assays were batched and performed using the Rotor-Gene 6000 (Corbett 
Research) real time analyser. Each 25μl reaction contained 5μl of extracted DNA (at 
a 1:10 dilution to reduce the effect of co-purified inhibitors from the blood culture broth), 
0.5μl (200 nM) each of the forward primer, reverse primer and probe, 12.5μl of 
LightCycler® 480 Probes Master (Roche Life Science) master mix and 6μl of PCR 
grade water (16). A no template control and a S. pneumoniae positive DNA control (S. 
pneumoniae ATCC 49619) were included in every PCR run. DNA was amplified using 
the following cycling conditions: 95°C for 5 minutes (activation) followed by 40 cycles 
of 95°C for 10 seconds (denaturation) and 60°C for 1 minute (amplification and 
detection). Results were analysed using the instrument’s software (Rotor-Gene 6000 
Series Software 1.7). We used a cycle threshold (CT) cut-off value of ≤ 22 to determine 
positivity. This value was chosen based on review of the CT values in samples with 
software-detected signal (Figure 2) and receiver operating characteristic (ROC) curve 
analysis of these samples. For ROC curve analysis we considered S. pneumoniae 
culture positive samples as true positives, and culture positive samples with organisms 
other than S. pneumoniae as true negatives. ROC curve analysis suggested that the 
optimal CT cut-off value for determining a positive PCR result was between 17 and 22 
(AUC 0.99), and the upper interval was selected as our CT cut-off value for positivity.  
Reference Methods: 
Culture was selected as a reference method as it is the current ‘gold standard’ for the 
diagnosis of pneumococcal disease. PCR was selected as an additional reference 
method as it is well-recognised and recommended by the CDC as a culture-
independent method for diagnosing pneumococcal disease and is especially useful if 
samples do not yield growth on culture and Gram stain results are suggestive of 
pneumococcal disease(16). The combination of culture positivity for S. pneumoniae or 
20 
 
PCR positivity was chosen as a composite reference method to create an improved 
reference standard that would also allow for the inclusion of culture-negative samples. 
ICT was compared to culture positivity for S. pneumoniae, PCR positivity and the 
composite reference of culture positivity for S. pneumoniae or PCR positivity. Gram 
stain with gram-positive cocci in pairs was also compared against culture positivity for 
S. pneumoniae, PCR positivity and the composite reference of culture positivity for S. 
pneumoniae or PCR positivity. This analysis was performed to determine if, by adding 
ICT to Gram stain as an adjunctive test, one could increase the yield of pneumococcal 
disease that could be identified immediately after blood culture signals positive and 
Gram stain is performed, in our setting  
Sample size:  
An online sample size calculator and an additional manual calculation method were 
used to estimate the sample size needed to power the study using the following 
parameters: prevalence of S. pneumoniae from blood cultures in our laboratory with 
gram-positive cocci in pairs, chains or where cocci could not be distinguished from 
those in clusters = 20%, hypothesised sensitivity and specificity of the ICT using blood 
culture broth after signalling positive = 99% and 82% respectively (based on 
performance on blood culture broth in previous studies)(11, 12, 29, 30), desired 
precision = 95%, and desired confidence interval = 90%(32-34). To meet these criteria 
a sample size ≥ 201 was required. 
Definitions:  
Definitions of community or hospital-acquired infection were modifications of those 
suggested by Friedman et al.(35). A positive blood culture was classified as 
community-acquired if it was taken within 48 hours of admission and the patient had 
not been admitted to hospital in the previous 3 months. A positive blood culture was 
classified as hospital-acquired if it was taken after 48 hours of admission or if the 
patient had been admitted to hospital in the previous 3 months.  
Ethics:  
The study was approved by the Human Research Ethics Committee at the University 





Data was analysed using Stata version 14.2 (Stata Corp, College Station, TX) and 
Microsoft Excel. Summary statistics were used to describe clinical, laboratory and 
epidemiological characteristics. Categorical variables were compared between groups 
using the chi-square test. Time between events was compared between groups using 
the Wilcoxon rank sum test for non-parametric data. Receiving operator characteristic 
(ROC) curves were generated to determine the optimum real-time PCR CT cut-off 
value for positivity. Diagnostic accuracy (sensitivity and specificity with 95% 
confidence intervals) was calculated using the DIAGTEST Stata module for each, 
Gram stain appearance with gram-positive cocci in pairs and ICT, versus culture 
positivity for S. pneumoniae, PCR positivity or the combination of culture positivity for 



















Chapter 3: Results 
Sample collection: 
We tested 212 blood culture samples that had signalled positive with gram-positive 
cocci in pairs, chains, or indeterminate morphology on microscopy. Samples were 
obtained from 193 patients and duplicate samples from the same patient were either 
collected on a different day, on the same day at a different time or on the same day at 
the same time but from different lumens of a central venous catheter.  
Clinical, laboratory and epidemiological characteristics of samples: 
Based on culture results, we grouped samples into the S. pneumoniae group (Spn), 
the Non-S. pneumoniae group (NSpn) (growth of gram-positive organisms other than 
S. pneumoniae) and the no growth (NG) group and the characteristics of each are 
summarised in Table 1. Several significant differences were noted between the 
Spn/NG groups and the NSpn group. Most samples from the Spn and NG groups were 
community-acquired infections and most of these samples were referred from primary 
and secondary level care facilities, whereas the converse applied to the NSpn group 
(P<0.001). The most common clinical syndromes in the Spn and NG groups were 
respiratory illness and meningitis (P<0.001) whilst other illnesses predominated in the 
NSpn group. There was limited data available for all the groups regarding antibiotic 
exposure prior to culture and no conclusions could be drawn as a result. Significant 
differences in the proportions of samples demonstrating autolysis were noted between 
each of the three groups with 94% in the NG group, 56% in the Spn group, and 16% 
in the NSpn group demonstrating autolysis(P<0.001). Significant differences in Gram 
stain morphology between all groups where found except when comparing the Spn 
group to the NG group. Gram-positive cocci in pairs was the predominant morphology 
on Gram stain for the Spn (69%) and NG groups (88%), whereas for the NSpn group 





Table 1: Clinical, laboratory and epidemiological characteristics of samples after 






N = 55 
NSpn group 
N = 140 
NG group 










N % N % N %    
Hospital of origin 
Tertiary hospital/Groote 
Schuur Hospital 
12 22 66 47 2 12    
Non-tertiary facility / 
Other 
43 78 74 53 15 88    
       P=<0.001* P=0.001* P=0.360 
Community versus Nosocomial infection 
Community  37 67 52 37 14 82    
Nosocomial 17 31 88 63 3 18    
No data 1 2 0 0 0 0    
       P=<0.001* P=<0.001* P=0.461 
Clinical 
Respiratory illness 34 62 22 16 9 53    
Meningitis 7 13 4 3 2 12    
Other 2 4 86 61 1 6    
No data 12 22 28 20 5 9    
       P=<0.001* P=<0.001* P=0.884 
Gram Stain 
Pairs 38 69 27 19 15 88    
Chains 16 29 63 45 1 6    
Cocci 1 2 50 36 1 6    
       P<0.001* P<0.001* P=0.112 
Autolysis 
Yes  31 56 22 16 16 94    
No  24 44 118 84 1 6    
       P=<0.001* P=<0.001* P=0.004 
* Significant differences between groups (defined as P ≤ 0.001) 
Spn: Growth of S. pneumoniae on culture 
NSpn: Growth of an organism other than S. pneumoniae on culture 
NG: No growth of any organism on culture   
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Median time intervals between incubation and signal detection of growth by the 
automated blood culture system and between incubation and authorisation of the Spn, 
NSpn and NG groups have been summarised in Table 2, for all but 3 samples from 
the NSpn group, where the data was not available. Median time intervals between 
incubation and signal detection of growth by the automated blood culture system was 
shorter in the Spn (10.2 hours, IQR 8.1-12.2 hours) group than in the NSpn (13.8 
hours, IQR 10.7-18.7) group and this finding was significant (P<0.001). However, there 
was no significant difference in the time interval between incubation and authorisation 
between these 2 groups. Time intervals from incubation to authorisation in the Spn 
(69.8 hours, IQR 62.6-88.4 hours) group was shorter than in the NG (102.2 hours, IQR 
76.3-212.1 hours) group and this finding was significant (P<0.001). 
 
Table 2: Median time intervals between incubation and signal detection by the 
automated blood culture system, and incubation to authorisation of blood culture 
samples, after being grouped according to culture positivity for S. pneumoniae. 
 
 
Test results and diagnostic accuracy analysis:  
On Gram stain, 80/212 (38%) samples had gram-positive cocci in pairs, of which 38/80 
(47%) were culture positive for S. pneumoniae, 27/80 (34%) were culture-positive for 
organisms other than S. pneumoniae and 15/80 (19%) were culture-negative. Gram-
 
Spn group 
N = 55 
NSpn group 
N = 140 
NG group 







 Hrs IQR Nr Hrs IQR Nr Hrs IQR Nr   
Incubation to 
signal detection 
10.2 8.1–12.2  13.8 10.7-18.7  10.2 8.8–10.8    
   55   137#   17 P<0.001* P=0.080 
Incubation to 
authorisation  
69.8 62.6–88.4  69.7 59.5–92.2  102.2 76.3–212.1    
   55   137#   17 P=0.486 P<0.001* 
# Data not available for 3 samples in the NSpn group 
* Significant differences between groups (defined as P ≤ 0.001)  
Hrs = hours, IQR = Interquartile range, Nr = Sample number 
Spn: Growth of S. pneumoniae on culture 
NSpn: Growth of an organism other than S. pneumoniae on culture 
NG: No growth of any organism on culture   
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positive cocci in chains were found in 80/212 (38%) samples and of these16/80 (20%) 
were culture positive for S. pneumoniae, 63/80 (79%) were culture-positive for 
organisms other than S. pneumoniae and 1/80 (1%) was culture-negative. The 
remaining 52/212 (24%) samples were classified as gram-positive cocci, where it was 
unclear on microscopy if the cocci were in clusters, pairs or chains. Of these samples, 
1/52 (2%) was culture positive for S. pneumoniae, 50/52 (96%) were culture-positive 
for organisms other than S. pneumoniae and 1/52 (2%) was culture-negative. 
S. pneumoniae was isolated from 55/212 (26%) samples. Of these S. pneumoniae 
culture-positive samples, Gram staining revealed that 38/55 (69%) had gram-positive 
cocci in pairs, 16/55 (29%) had gram-positive cocci in chains, and 1/55 (2%) was 
described as gram-positive cocci. Gram-positive organisms other than S. pneumoniae 
(non-S. pneumoniae) were cultured in 140/212 (66%) samples. On Gram stain of 
these samples, 27/140 (19%) had gram-positive cocci in pairs, 63/140 (45%) had 
gram-positive cocci in chains, and 50/140 (36%) had gram-positive cocci. The 
remaining 17/212 samples (8%) did not yield growth of any organism on culture and 
15/17 (88%) had gram-positive cocci in pairs, 1/17 (6%) had gram-positive cocci in 
chains, and 1/17 (6%) had gram-positive cocci on Gram stain.  Gram stain results 
classified according to culture positivity for S. pneumoniae can be found in Figure 1. 
Pneumococcal antigen was detected using the BinaxNOW Streptococcus 
pneumoniae Antigen Card Test (ICT). ICT was positive in 89/212 (42%) samples. S. 
pneumoniae was cultured in 55/89 (62%) of these samples, and the remaining ICT 
positive samples either had no growth on culture (n=17) (19%) or grew gram-positive 
organisms other than S. pneumoniae (n=17) (19%). S. pneumoniae was not cultured 
from any of the 123/212 (58%) ICT negative samples, and other gram-positive 
organisms were cultured from all these samples.  ICT results classified according to 
culture positivity for S. pneumoniae can be found in Figure 1. 
Distribution of PCR CT values in signal positive isolates based on culture results has 
been displayed in Figure 2. PCR was classified as positive if the CT value of the 
detected signal in the sample was ≤ 22. PCR was classified as negative if there was 
no detected signal in the sample, or if the CT value of the detected signal was > 22. 
Using this CT value cut-off, PCR was positive in 71/212 (33%) samples, of which S. 
pneumoniae was cultured in 54/71 (76%) of these samples, gram-positive organisms 
other that S. pneumoniae in 1/71 (1%) of these samples, and 16/71 (23%) of these 
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samples did not yield growth of any organism on culture. There were 141/212 (67%) 
PCR negative samples, and these yielded gram-positive organisms other that S. 
pneumoniae on culture in 139/141 (98%) of these samples, S. pneumoniae in 1/141 
(1%) of these samples, and 1/141 (1%) of these samples did not yield growth of any 
organism on culture. PCR results classified according to culture positivity for S. 




Figure 1: Percentage distribution and number of samples for Gram stain, ICT and PCR 

























































































Figure 2: Distribution of PCR cycle threshold (CT) values in signal positive samples 
based on culture positivity for S. pneumoniae. 
 
In summary, culture yielded S. pneumoniae in 55/212 (26%) samples, ICT was 
positive in 89/212 (42%) samples, and PCR was positive in 71/212 (33%) samples. 
Analysis of concordance between ICT and PCR with culture was performed and is 
summarised in Figure 3. For 54/55 (98%) S. pneumoniae culture-positive samples, 
both ICT and PCR results were positive. The 1/55 (2%) remaining S. pneumoniae 
cultured isolate was ICT positive and was detected on lytA PCR but classified as PCR-
negative, based on CT value = 26, above the established cut-off for our study. For the 
140/212 (66%) samples which cultured gram-positive organisms other than S. 
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pneumoniae, 123/140 (88%) samples were both ICT and PCR negative, 1/123 (1%) 
sample was both ICT and PCR positive, and for the remaining 16/140 (11%) samples 
ICT was positive but PCR was negative. ICT and PCR were positive for 16/17 (94%) 
culture-negative samples and ICT positive but PCR negative on 1 (6%) sample. All 
ICT and PCR results which were discordant with culture or each other were repeated 
with no change in results. Discrepant results are summarised in Table 3. 
 
Figure 3: Concordance of ICT and PCR results with culture results 
 
212 Samples
55 S. pneumoniae 
culture-positive
54 ICT and PCR  
Positive
1 ICT Positive and 
PCR Negative (CT=26)
140 non S. pneumoniae 
culture-positive
123 ICT and PCR 
Negative
1 ICT and PCR
positive (CT=13.76) 
16 ICT Positive and 
PCR Negative
17 no growth detected  
on 
culture
16 ICT and PCR 
Positive




Table 3: Discordant Antigen (ICT)/PCR results when compared with culture 
 
Culture Results Antigen (ICT) PCR CT value 
Culture and antigen positive for S. pneumoniae but PCR negative 
S. pneumoniae + coagulase negative staphylococcus  Positive Negative 26.00 
Culture negative for S. pneumoniae but antigen and PCR positive for S. pneumoniae 
Coagulase negative staphylococcus Positive Positive 13.76 
Culture and PCR negative for S. pneumoniae but antigen positive 
E. faecium + coagulase negative staphylococcus  Weak positive Negative  
S. agalactiae Weak positive Negative  
S. anginosus Weak positive Negative  
E. faecalis + coagulase negative staphylococcus Weak positive Negative  
Viridans streptococcus Positive Negative  
Viridans streptococcus* Positive Negative 25.04 
S. mitis* Positive Negative 26.49 
S. mitis* Positive Negative 26.32 
S. mitis Positive Negative 25.69 
S. mitis Positive Negative  
S. mitis + coagulase negative staphylococcus Positive Negative  
S. alactolyticus Positive Negative  
Coagulase negative staphylococcus Positive Negative  
Skin flora~ Positive Negative 29.22 
Skin flora~ Positive Negative  
Skin flora~ Positive Negative  
No growth on culture and PCR negative but antigen positive 
No growth  Positive Negative  
* Isolates from the same patient 
~ Skin flora were mixed viridans streptococci +/- coagulase negative staphylococcus  
 
We determined the sensitivity and specificity of ICT compared to culture positivity with 
S. pneumoniae, PCR positivity and the composite of culture or PCR positivity for S. 
pneumoniae as reference methods, for all samples, as well as for subsets based on 
Gram stain morphology, or based on a clinical history compatible with pneumococcal 
disease (i.e. respiratory illness or meningitis). Results are summarised in Table 4. 
Analysis of samples after exclusion of duplicate samples did not alter estimates of 
sensitivity and specificity significantly and results can be found in Table 6 in the 
appendix.  The sensitivity of ICT was 100% (95% CI 100 - 100%) compared to culture, 
PCR and the composite of culture or PCR positivity. Whilst the specificity of ICT was 
87 - 88% (95% CI 83 - 92%), this increased to 93 – 96% (95% CI 92-100%) when 
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used in the subset of samples with gram-positive cocci in pairs on Gram stain or if the 
clinical history was suggestive of respiratory illness or meningitis using the same 
reference standards.  
 
Table 4: Diagnostic accuracy of ICT when compared to culture positivity for S. 
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In order to assess incremental yield of ICT over usage of Gram stain morphology with 
gram-positive cocci in pairs to diagnose pneumococcal disease, diagnostic accuracy 
analysis was performed, comparing each to culture positivity for S. pneumoniae, PCR 
positivity and the composite of culture or PCR positivity for S. pneumoniae as the 
reference standards. The sensitivity and specificity of Gram stain with gram-positive 
cocci in pairs alone was 69 - 75% (95% CI 63-81%) and 81% (95% CI 75-86%) 
respectively which is too low to use as a diagnostic test for the identification of 
pneumococcal disease (Table 5). However, sensitivity and specificity of ICT was both 
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higher that Gram stain morphology of gram-positive cocci in pairs and was 100% (95% 
CI 100 – 100%) and 87 - 88% (95% CI 83 - 92%) respectively (Table 4) suggesting a 
role for its use in combination with Gram stain for the rapid identification of S. 
pneumoniae bacteraemia. These estimates of sensitivity and specificity did not change 
significantly after duplicate samples were excluded and these results can be found in 
Table 7 in the appendix. A similar increase in diagnostic accuracy yield was also 
identified in the subset of samples that had a clinical history of meningitis or respiratory 
illness.  
 
Table 5: Diagnostic accuracy of gram-positive cocci in pairs when compared to culture 
positivity for S. pneumoniae, PCR positivity and the composite of culture or PCR 
positivity for S. pneumoniae. 
 
 
Diagnostic accuracy of gram-
positive cocci in pairs 
compared to culture positivity 
for S. pneumoniae 
Diagnostic accuracy of 
gram-positive cocci in pairs 
compared to PCR positivity 
Diagnostic accuracy of gram-
positive cocci in pairs 
compared to culture or PCR 











































Of the 17 (8%) samples with no growth, 15/17 (88%) had gram-positive cocci in pairs 
and were both ICT and PCR positive. For the remaining 2/17 (12%) samples, 1/17 
(6%) was classified as Gram positive cocci and was both ICT and PCR positive, and 





Chapter 4: Discussion and Conclusions 
S. pneumoniae is a significant cause of mortality and morbidity in both the developed 
and developing world and no ideal gold standard test for the diagnosis of invasive 
pneumococcal disease (IPD) is available. We wanted to determine if the BinaxNOW 
Streptococcus pneumoniae Antigen Card test (ICT) would enable us to rapidly identify 
S. pneumoniae from blood culture samples immediately when Gram stain is 
suggestive of pneumococcus as being the causative organism of infection, as well as 
being an alternative method to PCR for identification of S. pneumoniae in culture-
negative samples. 
Based on the clinical, laboratory and epidemiological information that we collected with 
our samples, we observed that most isolates from the S. pneumoniae (n=55)(Spn) / 
no-growth (n=17)(NG) groups had gram-positive cocci in pairs (53/72, 74%)(P<0.001), 
and had autolysed (47/72, 65%)(P<0.001) when compared to the Non-S. pneumoniae 
group (n=140)(NSpn), and that these differences were statistically significant. Also 
statistically significant was that respiratory illness and meningitis were the most 
common clinical syndromes in both the Spn and NG groups (P<0.001), and most of 
these were community acquired (P<0.001), when compared to the NSpn group. These 
similarities between the Spn and NG groups further add to the suggestion that culture-
negative samples are most likely S. pneumoniae that have autolysed and would 
benefit from an easier more rapid presumptive identification tool of IPD such as ICT. 
Minimal data was available regarding antibiotic exposure prior to cultures being 
collected and no conclusions could be drawn from this.  
ICT was positive in all samples from the Spn (n=55) and NG (n=17) groups. One 
isolate from the NG group was PCR negative, with no signal detected, and the rest 
were PCR positive. This negative PCR result was confirmed as negative, by our 
reference laboratory using a different lytA PCR and CT cut-off value of ≤ 39.9 to 
determine positivity. This sample, even though it exhibited gram-positive cocci in 
chains was considered to be an ICT false positive result, as the patient presented with 
meningitis, but CSF investigations were in keeping with viral meningitis and CSF PCR 
was positive for enterovirus. CSF microscopy and bacterial culture were both negative.  
In the Spn group (n=55), only 1 sample was ICT positive but PCR negative, and this 
PCR negative result was based on a CT value of 26. Culture results of this sample 
indicated it was mixed and included growth of both S. pneumoniae and coagulase 
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negative staphylococcus (CoNS). This false negative PCR result is the result of our 
experimentally determined CT cut-off value, and the reduced yield of S. pneumoniae 
DNA, as indicated by the higher CT value.   
The NSpn group (n=140) had 17 samples which were ICT positive. However, only 1 
of these 17 samples was PCR positive, with a CT value of 13.76. Gram positive cocci 
were observed on Gram stain of this isolate and culture only yielded growth of CoNS. 
It is unlikely that both ICT and PCR were falsely positive, especially with the low PCR 
CT value. It is extremely likely that S. pneumoniae was present in the sample, but was 
non-viable, or that the quantity of CoNS was much higher than S. pneumoniae and 
outcompeted it on culture. The remaining 16 isolates were all PCR negative. Only 5/16 
of these had signal detected on PCR with CT values that ranged between 25.04 – 
29.22. It is possible that S. pneumoniae was present in these 5 samples but were non-
viable or outcompeted by growth of the other organisms. Positive reactions with ICT, 
in the above 16 samples, was observed with growth of viridans streptococci, E. 
faecalis, E. faecium, CoNS, mixed skin flora, S. alactolyticus and S. agalactiae in our 
study (Table 3). The cross-reactivity of ICT with viridans streptococci, enterococcus 
species and S. agalactiae has also been observed in other studies(17, 29, 30).  
The benefit of the BinaxNOW Streptococcus pneumoniae Antigen Card test as an 
adjunct for the diagnosis of S. pneumoniae bacteraemia, particularly in culture-
negative specimens has been demonstrated by others. Petti and colleagues showed 
that ICT performed on blood culture broth that yielded growth of S. pneumoniae on 
culture  remains positive even after these isolates became non-viable on culture, by 
testing blood culture broth on day 30 after signalling positive(12). Baggett and 
colleagues, demonstrated that ICT was positive in 43/182 (24%) signal positive blood 
culture samples that did not yield growth of an organism on culture, potentially 
increasing the diagnostic yield of S. pneumoniae disease, however, false positives 
results could not be excluded as no confirmatory tests were performed for IPD(11). In 
the study by Saha and colleagues, 8/10 culture-negative specimens that were brown 
or ‘chocolate’ coloured in appearance were ICT positive and confirmed to have IPD 
with ply PCR, increasing the diagnostic yield of IPD. Altun and colleagues compared 
ICT and three latex agglutination kits with culture for the diagnosis of IPD(29). They 
performed each test directly on blood culture broth that had flagged positive with gram-
positive cocci in pairs or chains on microscopy, which is the most similar to what we 
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had done(29). They reported that, ICT had the best sensitivity (100% vs 99.6% in each 
of the other methods) but the worst specificity (64.1% vs 82.6 – 89.1%) as it cross 
reacted with other streptococcal and enterococcal species. Specificity in this study, 
was potentially underreported, as no confirmatory molecular testing was performed for 
IPD, and they had 33/92 (36%) samples that had growth of other gram-positive 
organisms that were ICT positive, and the presence of S. pneumoniae that had either 
autolysed or were outcompeted in growth on culture could not be excluded(29). Moisi 
and colleagues also performed ICT directly on signal positive blood cultures in Mali 
and Thailand, but this was done irrespective of Gram stain results. These samples 
had lytA PCR performed but they used a CT cut-off value of < 35 to determine 
positivity(30). This study had country specific inclusion criteria and patient populations 
were different between the 2 sites. Both ICT and PCR were compared to routine 
culture. Sensitivity of ICT and PCR was 87-100% and 90-100% respectively. 
Specificity of ICT and PCR was 96-100% and 98-100% respectively with PCR 
outperforming ICT(30). In our study, sensitivity of ICT when compared to culture, PCR 
or the composite of culture or PCR positivity for S. pneumoniae, was 100% and is 
similar to what Altun and colleagues and Moisi and colleagues had reported. 
Specificity of ICT in our study was 87-88% when compared to culture, PCR or the 
composite of culture or PCR positivity for S. pneumoniae and was compromised 
mostly by cross-reactivity with viridans streptococci, CoNS and enterococcus species. 
Specificity of ICT increased to 93 – 96% if used in the subset of samples that had 
clinical histories compatible with meningitis or respiratory disease (n=78) or had gram-
positive cocci in pairs on Gram stain (n=80). Specificity of ICT in our study was higher 
than what Altun and colleagues (64%) had reported and lower than what Moisi and 
colleagues (96-100%) had reported. However, the availability or the distribution of 
Gram stain results and clinical details of patient samples were not available in either 
and may have affected the performance of the test.  
Pragmatically, when blood culture systems detect potential growth in a sample, they 
emit a signal alerting laboratory staff, and Gram stain is an easily accessible test 
available to laboratory staff with immediate results. The sensitivity and specificity of 
Gram stain with gram-positive cocci in pairs for presumptively identifying 
pneumococcal disease when compared to culture, PCR or the composite of culture or 
PCR positivity for S. pneumoniae was 69-75% and 80-81% respectively. With ICT, 
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sensitivity and specificity were both higher when compared to using Gram stain with 
gram-positive cocci in pairs for identifying IPD and were 100% and 87-88% 
respectively, even after duplicate samples were removed from analysis, clearly 
indicating a role for ICT as an adjunctive test in the preliminary identification of S. 
pneumoniae bacteraemia especially in a setting like ours where clinical history and 
Gram stain morphology is readily available. 
Turnaround time is often used as a quantifiable key performance indicator in busy 
diagnostic laboratories to measure performance levels. The difference in turnaround 
time measured from incubation in the automated blood culture system to authorisation 
between the S. pneumoniae (69.8 hours) versus the no-growth group (102.2 hours) 
was significant (P<0.001). This time delay in providing results could potentially 
influence clinical management and appropriate antibiotic de-escalation to a narrower 
spectrum antibiotic in the appropriate clinical context. ICT could improve turnaround 
time for identification as this result would be available within an hour of the blood 
culture system signalling positive.  
Although the number of culture-negative samples (n=17) were small, PCR was 
concordant with ICT in all but 1 sample, advocating that ICT be a potential alternative 
to PCR for the preliminary diagnosis of IPD, in culture-negative samples. The main 
advantage would be the improvement in turnaround times in settings where PCR is 
not readily available. 
A major limiting factor in our study is the lack of an appropriate reference standard to 
adequately assess the diagnostic accuracy of ICT. We used culture positivity for S. 
pneumoniae, PCR positivity and the composite of culture or PCR positivity for S. 
pneumoniae as our reference methods, but both culture and PCR are flawed. In our 
study, PCR positivity was determined by using a CT cut off value of ≤ 22. This value 
was chosen based on review of the CT values in specimens with detected signal 
(Figure 2) and ROC curve analysis. For ROC curve analysis we considered S. 
pneumoniae culture-positive samples as true positives and culture-positive samples 
with organisms other than S. pneumoniae as true negatives. ROC curve analysis 
suggested that the optimal CT cut-off value to determine positivity was between 17 
and 22 (AUC 0.99). These values are considerably lower than the conventional 
diagnostic PCR CT cut-off value (~37), but our samples were blood culture broth and 
hence classified as enriched media allowing for good growth of organisms and a lower 
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CT cut-off value was expected. The mean CT value for S. pneumoniae culture-positive 
samples was 13.8 (range 9.0 – 26.0), 30.5 (range 13.8 – 36.9) for specimens that grew 
organisms other than S. pneumoniae and 11.6 (range 9.7-13.5) for specimens that 
were culture-negative. Using our CT cut-off value resulted in one false negative PCR 
result. Additionally, in the NSpn group, there were 5 samples that were ICT positive 
and had signal detected on PCR with CT values that ranged between 25.04 – 29.22. 
It is possible that S. pneumoniae was present in these samples at low levels, and were 
truly PCR positive, but were non-viable or out-competed by growth of other organisms, 
resulting in the ICT being incorrectly labelled as false positive and hence affecting the 
specificity of the test. A further limitation of the study was to follow the ICT 
manufacturer’s instruction that weak positive results should be reported as positive for 
S. pneumoniae. We only had 4 samples that were weak positive but all of these 
samples had growth of gram-positive organisms other than S.pneumoniae on culture 
and all were PCR negative with no signal detected. Whilst these numbers were small, 
we would recommend against reporting these weak positive results as S. pneumoniae 
invasive disease.    
In conclusion, accurate diagnosis of IPD is challenging with current diagnostics. ICT 
is a useful adjunctive diagnostic tool that improves turnaround time in the identification 
of IPD but is limited by cross-reactivity with other streptococcal and enterococcal 
species. In a setting like ours where Gram stain morphology and clinical history is 
available, the test still offers added value, especially in the midst of antimicrobial 
resistance and a shift toward antibiotic stewardship programs targeting appropriate 
antibiotic use and rapid de-escalation of broad-spectrum antibiotics to narrow 
spectrum antibiotics, if appropriate. In our setting, ICT has the potential to impact 
patient care and antibiotic stewardship, as high-level penicillin resistance, defined as 
MIC ≥ 2μg/mL is still relatively low (~ 7%) and rapid de-escalation to penicillin is 
possible, in the appropriate clinical setting. ICT is potentially a suitable alternative to 
molecular testing for the identification of S. pneumoniae bacteraemia in culture-
negative specimens, however due to small numbers of culture-negative samples 






Table 6: Diagnostic accuracy of ICT when compared to culture positivity for S. 
pneumoniae, PCR positivity and the composite of culture or PCR positivity for S. 
pneumoniae after exclusion of duplicate samples. 
 
 
Diagnostic accuracy of ICT 
when compared with 
culture positivity for 
S.pneumoniae 
Diagnostic accuracy of ICT 
when compared to PCR 
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Table 7: Diagnostic accuracy of gram-positive cocci in pairs when compared to culture 
positivity for S. pneumoniae, PCR positivity and the composite of culture or PCR 
positivity for S. pneumoniae after exclusion of duplicate samples 
 
 
Diagnostic accuracy of gram-
positive cocci in pairs 
compared to culture positivity 
for S. pneumoniae 
Diagnostic accuracy of 
gram-positive cocci in pairs 
compared to PCR positivity 
Diagnostic accuracy of 
gram-positive cocci in pairs 
compared to culture or PCR 













All isolates after 
removal of 
duplicate samples 
(n=193) 
69 
(62-75%) 
80 
(74-86%) 
74 
(68-80%) 
80 
(75-86%) 
73 
(67-79%) 
80 
(75-86%) 
Clinical history 
compatible with 
pneumococcal 
disease after 
removal of 
duplicate samples 
(n=76) 
65 
(53-77%) 
80 
(70-90%) 
70 
(60-80%) 
81 
(72-90%) 
69 
(59-79%) 
80 
(71-89%) 
 
 
